##  [Biomedical Research Business Development & Licensing](/research-and-development/collaborations/biomedical-research-business-development-licensing "Biomedical Research Business Development & Licensing") 

 Our Biomedical Research Business Development & Licensing team works with prospective partners to establish collaborations that are mutually beneficial and productive. We remain actively engaged with our collaborators to ensure a dynamic collaboration environment and maximize the probability of success.

The Biomedical Research Business Development & Licensing team is flexible in structuring deals and aims to tailor our collaborations to each partner’s individual needs. Deal types include in-licensing, out-licensing/risk-sharing, research collaborations, options, equity investments and acquisitions.

Our Biomedical Research Business Development & Licensing team seeks collaborations in most therapeutic areas and technology classes ([see table below](#table)), from idea-generation and early discovery through clinical proof-of-concept (phase IIa clinical trials). If you have an idea and would like to collaborate [learn more here](/partnering "Partnering").

Learn more about our approach to industry partnering from Phil Gotwals, Head of Biomedical Research Business Development & Licensing:

The Biomedical Research BD&L team seeks collaborations in the following areas:

Disease Areas PlatformsClinicalAutoimmunity, Transplantation &amp; Inflammatory DiseaseAntibody, Protein and Cell Therapies Target Discovery &amp; ValidationNeuroscienceMedical Chemistry and Library Enhancement Drug DiscoveryOphthalmologyTarget Discovery - Pathways Safety &amp; Drug MetabolismRespiratory DiseasesTranslational Medicine Proof of Concept Clinical StudyOncology/Immuno-oncologyPreclinical Safety and DMPK Clinical Trials Phase I - IIaMusculoskeletal DiseasesAssay Development  Cardiovascular, Renal &amp; Metabolism  <a class="ck-anchor" id="table" name="table"></a>